Swiss analysis of multiple sclerosis: a multicenter, non-interventional, retrospective cohort study of disease-modifying therapies.
about
Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.Reasons for discontinuation of subcutaneous interferon β-1a three times a week among patients with multiple sclerosis: a real-world cohort studyComparative effectiveness of interferons in relapsing-remitting multiple sclerosis: a meta-analysis of real-world studies.Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.The heritage of glatiramer acetate and its use in multiple sclerosis
P2860
Swiss analysis of multiple sclerosis: a multicenter, non-interventional, retrospective cohort study of disease-modifying therapies.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Swiss analysis of multiple scl ...... f disease-modifying therapies.
@en
Swiss analysis of multiple scl ...... f disease-modifying therapies.
@nl
type
label
Swiss analysis of multiple scl ...... f disease-modifying therapies.
@en
Swiss analysis of multiple scl ...... f disease-modifying therapies.
@nl
prefLabel
Swiss analysis of multiple scl ...... f disease-modifying therapies.
@en
Swiss analysis of multiple scl ...... f disease-modifying therapies.
@nl
P2093
P2860
P356
P1433
P1476
Swiss analysis of multiple scl ...... f disease-modifying therapies.
@en
P2093
Chiara Zecca
Claudio Gobbi
Emmanuela Borter
Martin Traber
Michael Linnebank
Rosetta Meier
Stefanie Müller
Xiaojun You
P2860
P356
10.1159/000346761
P577
2013-05-14T00:00:00Z